Effect of Intensive Glycemic Lowering on Health-Related Quality of Life in Type 2 Diabetes

Abstract

The ACCORD trial strategy of intensive glycemic control did not lead to benefits in HRQL and was associated with modest improvement in diabetes treatment satisfaction. Thus patient acceptability was apparently not compromised with intensive and complex interventions such as those used in ACCORD.